1. Home
  2. ARCT vs FTHY Comparison

ARCT vs FTHY Comparison

Compare ARCT & FTHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • FTHY
  • Stock Information
  • Founded
  • ARCT 2013
  • FTHY 2020
  • Country
  • ARCT United States
  • FTHY United States
  • Employees
  • ARCT N/A
  • FTHY N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • FTHY Investment Managers
  • Sector
  • ARCT Health Care
  • FTHY Finance
  • Exchange
  • ARCT Nasdaq
  • FTHY Nasdaq
  • Market Cap
  • ARCT 444.5M
  • FTHY 500.1M
  • IPO Year
  • ARCT N/A
  • FTHY N/A
  • Fundamental
  • Price
  • ARCT $13.08
  • FTHY $14.02
  • Analyst Decision
  • ARCT Strong Buy
  • FTHY
  • Analyst Count
  • ARCT 7
  • FTHY 0
  • Target Price
  • ARCT $57.80
  • FTHY N/A
  • AVG Volume (30 Days)
  • ARCT 451.8K
  • FTHY 176.7K
  • Earning Date
  • ARCT 05-07-2025
  • FTHY 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • FTHY 10.93%
  • EPS Growth
  • ARCT N/A
  • FTHY N/A
  • EPS
  • ARCT N/A
  • FTHY N/A
  • Revenue
  • ARCT $152,310,000.00
  • FTHY N/A
  • Revenue This Year
  • ARCT N/A
  • FTHY N/A
  • Revenue Next Year
  • ARCT $39.21
  • FTHY N/A
  • P/E Ratio
  • ARCT N/A
  • FTHY N/A
  • Revenue Growth
  • ARCT N/A
  • FTHY N/A
  • 52 Week Low
  • ARCT $8.04
  • FTHY $12.66
  • 52 Week High
  • ARCT $45.00
  • FTHY $14.74
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 60.60
  • FTHY 53.09
  • Support Level
  • ARCT $10.07
  • FTHY $13.49
  • Resistance Level
  • ARCT $11.00
  • FTHY $13.85
  • Average True Range (ATR)
  • ARCT 0.89
  • FTHY 0.35
  • MACD
  • ARCT 0.53
  • FTHY 0.05
  • Stochastic Oscillator
  • ARCT 100.00
  • FTHY 85.52

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

About FTHY First Trust High Yield Opportunities 2027 Term Fund

FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income.

Share on Social Networks: